16-56514589-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031885.5(BBS2):​c.209G>A​(p.Ser70Asn) variant causes a missense change. The variant allele was found at a frequency of 0.993 in 1,614,200 control chromosomes in the GnomAD database, including 796,560 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 1.0 ( 75444 hom., cov: 31)
Exomes 𝑓: 0.99 ( 721116 hom. )

Consequence

BBS2
NM_031885.5 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:13

Conservation

PhyloP100: 4.99

Publications

57 publications found
Variant links:
Genes affected
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
BBS2 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 74
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.8563224E-7).
BP6
Variant 16-56514589-C-T is Benign according to our data. Variant chr16-56514589-C-T is described in ClinVar as Benign. ClinVar VariationId is 285261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.99 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS2NM_031885.5 linkc.209G>A p.Ser70Asn missense_variant Exon 2 of 17 ENST00000245157.11 NP_114091.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS2ENST00000245157.11 linkc.209G>A p.Ser70Asn missense_variant Exon 2 of 17 1 NM_031885.5 ENSP00000245157.5

Frequencies

GnomAD3 genomes
AF:
0.995
AC:
151493
AN:
152224
Hom.:
75385
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.998
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.993
Gnomad ASJ
AF:
0.995
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.991
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.987
Gnomad NFE
AF:
0.993
Gnomad OTH
AF:
0.995
GnomAD2 exomes
AF:
0.994
AC:
249946
AN:
251430
AF XY:
0.994
show subpopulations
Gnomad AFR exome
AF:
0.998
Gnomad AMR exome
AF:
0.996
Gnomad ASJ exome
AF:
0.995
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.992
Gnomad OTH exome
AF:
0.991
GnomAD4 exome
AF:
0.993
AC:
1451988
AN:
1461858
Hom.:
721116
Cov.:
53
AF XY:
0.993
AC XY:
722103
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.999
AC:
33449
AN:
33480
American (AMR)
AF:
0.996
AC:
44552
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
26001
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39698
AN:
39698
South Asian (SAS)
AF:
0.990
AC:
85365
AN:
86256
European-Finnish (FIN)
AF:
0.999
AC:
53382
AN:
53420
Middle Eastern (MID)
AF:
0.986
AC:
5688
AN:
5768
European-Non Finnish (NFE)
AF:
0.993
AC:
1103818
AN:
1111980
Other (OTH)
AF:
0.994
AC:
60035
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
540
1081
1621
2162
2702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.995
AC:
151611
AN:
152342
Hom.:
75444
Cov.:
31
AF XY:
0.995
AC XY:
74130
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.998
AC:
41495
AN:
41562
American (AMR)
AF:
0.993
AC:
15197
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
3455
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5182
AN:
5182
South Asian (SAS)
AF:
0.991
AC:
4784
AN:
4828
European-Finnish (FIN)
AF:
1.00
AC:
10622
AN:
10626
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.993
AC:
67568
AN:
68044
Other (OTH)
AF:
0.995
AC:
2106
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.993
Hom.:
169784
Bravo
AF:
0.995
TwinsUK
AF:
0.993
AC:
3682
ALSPAC
AF:
0.992
AC:
3825
ESP6500AA
AF:
0.999
AC:
4390
ESP6500EA
AF:
0.992
AC:
8534
ExAC
AF:
0.994
AC:
120656
Asia WGS
AF:
0.997
AC:
3468
AN:
3478
EpiCase
AF:
0.992
EpiControl
AF:
0.992

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Nov 15, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 2 Benign:3
Nov 16, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Pathogenic:1Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Jan 01, 2013
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Sep 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa 74 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
18
DANN
Benign
0.31
DEOGEN2
Benign
0.23
T;.
Eigen
Benign
-0.085
Eigen_PC
Benign
0.026
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.39
T;.
MetaRNN
Benign
6.9e-7
T;T
MetaSVM
Benign
-0.91
T
PhyloP100
5.0
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
2.8
N;N
REVEL
Benign
0.27
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Vest4
0.077
MPC
0.23
ClinPred
0.0061
T
GERP RS
5.5
gMVP
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4784677; hg19: chr16-56548501; COSMIC: COSV107306301; COSMIC: COSV107306301; API